Amneal Pharmaceuticals (AMRX) Debt to Equity Ratio: 6.180

Amneal Pharmaceuticals, Inc. (AMRX)

21.38 -0.32 (-1.50%) USD | NASDAQ | Nov 13, 16:00

21.38 0.00 (0.00%) After-Hours: 19:59

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.

Date	Value
September 30, 2026	6.180
June 30, 2026	84.54
March 31, 2026	-59.38
December 31, 2025	-37.98
September 30, 2025	-24.54
June 30, 2025	-23.03
March 31, 2025	-19.59
December 31, 2024	-23.73
September 30, 2024	-28.31
June 30, 2024	-47.42
March 31, 2024	-43.09
December 31, 2023	139.05
September 30, 2023	8.477
June 30, 2023	8.985
March 31, 2023	9.691
December 31, 2022	9.534
September 30, 2022	9.606
June 30, 2022	10.34
March 31, 2022	7.328
December 31, 2021	7.982
September 30, 2021	8.227
June 30, 2021	8.430
March 31, 2021	9.040
December 31, 2020	9.711
September 30, 2020	9.837

Date	Value
June 30, 2020	9.720
March 31, 2020	10.30
December 31, 2019	11.92
September 30, 2019	12.72
June 30, 2019	6.054
March 31, 2019	5.912
December 31, 2018	5.332
September 30, 2018	5.737
June 30, 2018	5.628
March 31, 2018
December 31, 2017	-3.849
September 30, 2017
June 30, 2017
March 31, 2017	1.448
December 31, 2016	1.332
September 30, 2016	0.9184
June 30, 2016	0.4055
March 31, 2016	0.402
December 31, 2015	0.3997
September 30, 2015	0.5156
June 30, 2015	0.5886
March 31, 2015	0.4667
December 31, 2014	0.00
September 30, 2014	0.00
June 30, 2014	0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks